Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

Round Table with Drs. Anne Tsao and Alex Farivar, Part 2: Mesothelioma
Author
Howard (Jack) West, MD

This is part 2 of my round table case discussion with Dr. Anne Tsao, a medical oncologist and thoracic oncology expert from MD Anderson Cancer Center in Houston, and Dr. Alex Farivar, a thoracic surgeon with expert training in mesothelioma at Swedish Cancer Institute in Seattle. This particular case covers a patient with a mesothelioma, cancer of the lining around the lung, which is also known as malignant pleural mesothelioma.

Here is the audio and video versions of the podcast, along with the transcript and figures.

[powerpress]

round-table-with-drs-tsao-and-farivar-part-2-meso-case-audio-podcast

round-table-with-drs-tsao-and-farivar-part-2-meso-case-transcript

round-table-with-drs-tsao-and-farivar-part-2-meso-case-figures

By the way, my apologies for the poor audio quality, a combination of inadequate recording, passing buses outside of the public space we were in, etc. It's audible and still useful to people who are interested in learning about this topic, but this recording is below the standard for which we're striving. To be honest, part of the audio quality issue was that we went for a lower cost sound guy, and it shows. So please consider a contribution, because it goes for things like having our podcasts sound better. You get what you pay for, and we would prefer to do better than "shoestring budget" quality.

Next Previous link

Previous PostNext Post

Related Content

Article
The article describes the AVO treatment, a combination therapy for Chronic Lymphocytic Leukemia (CLL), particularly for high-risk patients. CLL is a slow-growing cancer where abnormal white blood cells accumulate. "High-risk" CLL refers to cases with specific genetic changes (e.g., in TP53) that make the disease harder to treat.
Image
2025 Spanish Targeted Therapy in Lung Cancer Patient Forum
Article
Da click aquí para más información y para registrarte ahora